Bruno Vincenzo Fiod Riccio

Prof. Bruno Vincenzo Fiod Riccio

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2019 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
Priscileila Colerato FerrariPriscileila Colerato Ferrari
Priscileila Colerato Ferrari
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Trans-resveratrol (TR) is the biological active isomer of resveratrol and the one responsible for therapeutic effects; both molecules are non-flavonoid phenolics of the stilbenes class found mainly in berries and red grapes. TR biological properties lie in modulation of various enzymatic classes. It is a promising candidate to novel drugs due its applications in pharmaceutical and cosmetic industries, such as anticarcinogenic, antidiabetic, antiacne, antioxidant, anti-inflammatory, neuroprotective, and photoprotector agent. It has effects on bone metabolism, gastrointestinal tract, eyes, kidneys, and in obesity treatment as well. Nevertheless, its low solubility in water and other polar solvents may be a hindrance to its therapeutic effects. Various strategies been developed to overcome these issues, such as the drug delivery systems. The present study performed a research about methods to identify TR and RESV in several samples (raw materials, wines, food supplements, drug delivery systems, and blood plasma). Most of the studies tend to analyze TR and RESV by high performance liquid chromatography (HPLC) coupled with different detectors, even so, there are reports of the use of capillary electrophoresis, electron spin resonance, gas chromatography, near-infrared luminescence, UV-Vis spectrophotometer, and vibrational spectrophotometry, for this purpose. Thus, the review evaluates the biological activity of TR and demonstrates the currently used analytical methods for its quantification in different matrices.

1 May 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
FBFranciele Garcia Baveloni Baveloni
Franciele Garcia Baveloni Baveloni
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
LFLeonardo Delello Di Filippo
Leonardo Delello Di Filippo
MFMariza Aires Fernandes
Mariza Aires Fernandes
AMAndréia Bagliotti Meneguin
Andréia Bagliotti Meneguin
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Administration of substances through the skin represents a promising alternative, in relation to other drug administration routes, due to its large body surface area, in order to offer ideal and multiple sites for drug administration. In addition, the administration of drugs through the skin avoids the first-pass metabolism, allowing an increase in the bioavailability of drugs, as well as reducing their side effects. However, the stratum corneum (SC) comprises the main barrier of protection against external agents, mainly due to its structure, composition and physicochemical properties, becoming the main limitation for the administration of substances through the skin. In view of the above, pharmaceutical technology has allowed the development of multiple drug delivery systems (DDS), which include liquid crystals (LC), cubosomes, liposomes, polymeric nanoparticles (PNP), nanoemulsions (NE), as well as cyclodextrins (CD) and dendrimers (DND). It appears that the DDS circumvents the problems of drug absorption through the SC layer of the skin, ensuring the release of the drug, as well as optimizing the therapeutic effect locally. This review aims to highlight the DDS that include LC, cubosomes, lipid systems, PNP, as well as CD and DND, to optimize topical skin therapies.

28 September 2022 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
ASAmanda Letícia Polli Silvestre
Amanda Letícia Polli Silvestre
AMAndreia Bagliotti Meneguin
Andreia Bagliotti Meneguin
TRTais de Cassia Ribeiro
Tais de Cassia Ribeiro
AKAna Beatriz Klosowski
Ana Beatriz Klosowski
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

4 September 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
LSLarissa Spósito
Larissa Spósito
GCGabriela Corrêa Carvalho
Gabriela Corrêa Carvalho
Priscileila Colerato FerrariPriscileila Colerato Ferrari
Priscileila Colerato Ferrari
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

16 January 2021 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
AKAna Beatriz Klosowski
Ana Beatriz Klosowski
EPEduardo Prestes
Eduardo Prestes
TSTaynara Barbosa de Sousa
Taynara Barbosa de Sousa
LMLaís Caroline de Assunção Morais
Laís Caroline de Assunção Morais
Priscileila Colerato FerrariPriscileila Colerato Ferrari
Priscileila Colerato Ferrari

27 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
ANAndré Luiz Carneiro Soares do Nascimento
André Luiz Carneiro Soares do Nascimento
AMAndréia Bagliotti Meneguin
Andréia Bagliotti Meneguin
CRCamila Fernanda Rodero
Camila Fernanda Rodero
KSKaio Pini Santos
Kaio Pini Santos
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Trans-resveratrol can promote various dermatological effects. However, its high crystallinity decreases its solubility and bioavailability. Therefore, solid dispersions have been developed to promote its amorphization; even so, they present as powders, making cutaneous controlled drug delivery unfeasible and an alternative necessary for their incorporation into other systems. Thus, polyvinylpyrrolidone (PVP) films were chosen with the aim of developing a controlled delivery system to treat inflammation and bacterial infections associated with atopic dermatitis. Four formulations were developed: two with solid dispersions (and trans-resveratrol) and two as controls. The films presented with uniformity, as well as bioadhesive and good barrier properties. X-ray diffraction showed that trans-resveratrol did not recrystallize. Fourier-transform infrared spectroscopy (FT-IR) and thermal analysis evidenced good chemical compatibilities. The in vitro release assay showed release values from 82.27 ± 2.60 to 92.81 ± 2.50% (being a prolonged release). In the in vitro retention assay, trans-resveratrol was retained in the skin, over 24 h, from 42.88 to 53.28%. They also had low cytotoxicity over fibroblasts. The in vivo assay showed a reduction in inflammation up to 66%. The films also avoided Staphylococcus aureus’s growth, which worsens atopic dermatitis. According to the results, the developed system is suitable for drug delivery and capable of simultaneously treating inflammation and infections related to atopic dermatitis.